Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab

Klaus Bendtzen, Pierre Geborek, Morten Svenson, Lotta Larsson, Meliha C. Kapetanovic, Tore Saxne

Research output: Contribution to journalArticlepeer-review

332 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab'. Together they form a unique fingerprint.

Medicine & Life Sciences